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Abstract – Pyranonaphthoquinone natural products are widely distributed in 
plants and microorganisms and have diverse biological activities. Angular 
benzochromenes are a small class of natural products isolated from Conospermum 
and Pentas plants. Of these, conocurvone was isolated from Conospermum as a 
trimeric pyranonaphthoquinone that has potent anti-HIV activity. We have 
focused on the total synthesis of compounds that exhibit biological activity or 
whose activity is enhanced upon oligomerization.  This review describes the 
discovery and biological activities of the trimeric pyranonaphthoquinone 
conocurvone and related compounds, as well as our and other researchers’ 
synthetic studies toward monomeric pyranonaphthoquinones.
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1. INTRODUCTION 
Pyranonaphthoquinone (also called chromenoquinone) natural products have been isolated from various 
plants and bacteria and exhibit characteristic biological activities.1,2 Busseihydroquinones B-D (1-3) and 
pyranonaphthalene 4 were isolated from Pentas bussei as antiplasmodial compounds.3 Monomeric 
teretifolione B (5)4 and its trimeric conocurvone (6) were isolated from Conospermum plants. Compound 
6 exhibits anti-HIV-1 activity (Figure 1). The first part of this review provides background information 
regarding the isolation and studies on the biological activities of conocurvone (6) and related monomeric 
and oligomeric pyranonaphthquinones. The second part of this review discusses synthetic studies by our 
laboratory and others on monomeric pyranonaphthoquinones, including teretifolione B (5). 
 
 
Figure 1. Natural pyranonaphthoquinones isolated from Conospermum and Pentas plants 
 
2. ISOLATION AND STRUCTURAL DETERMINATION OF CONOCURVONE AND 
RELATED COMPOUNDS 
In 1975, Cannon et al.5 reported the isolation of ten quinones from Conospermum teretifolium 
(Proteaceae) roots, including the five new pyranonaphthoquinones 5 and 7-10 and the three 
 naphthoquinones 11-13. Of these compounds, teretifolione B (5) and the C8-methylated derivative 9 were 
isolated as angular pyranonaphthoquinones with one quaternary chiral center (Figure 2).  
Biological assays conducted at the U. S. National Cancer Institute showed that an extract of 
Conospermum plants exhibited inhibitory activity towards the cytopathic effects of HIV-1 infection. Boyd 
et al.6 explored the chemical constituents of this extract using bioassay-guided separation and isolated 
conocurvone, a compound with anti-HIV activity. 1H-NMR structural analysis provided a very complex 
spectrum with many highly overlapping resonances. For example, several components were observed 
whose abundance ratios depended on the solvent used and the temperature, suggesting a dynamic 
intramolecular process observable on the NMR time scale. The observation of multiple peaks upon HPLC 
analysis of conocurvone supported this result. High-resolution fast-atom bombardment mass spectrometry 
analysis showed the molecular formula of conocurvone to be C60H56O11. Negative-ion fast-atom 
bombardment mass spectrometry of deuterated conocurvone disclosed the presence of two exchangeable 
H atoms. Observation of the product ions derived from species with molecular weights one-third and 
two-thirds that of conocurvone indicated that 6 is the trimeric structure of monomeric 
pyranonaphthoquinone, which corresponds with monomeric teretifolione B (5). The complexity of the 
1H-NMR spectrum of conocurvone (6) was attributed to the slow tautomerization of the hydroquinone 
part and the existence of rotational isomers of the pyranonaphthoquinone unit. Acetylation of 
conocurvone (6) under reductive conditions using Zn dust in Ac2O gave the octaacetate whose 1H-NMR 
spectrum indicated a single entity without tautomerization or slow rotation on the NMR time scale. Mass 
spectrometry analysis showed that the compound corresponds to structure 14 (Scheme 1a).  
The structure of conocurvone (6) was elucidated by its semisynthesis from teretifolione B (5). First, the 
absolute configuration of teretifolione B (5) was determined as (R) by X-ray crystallographic analysis of 
the corresponding p-bromobenzoate 15. The reaction of 15 with thiophenol, followed by treatment of the 
resulting bis(thiophenol) derivative 16 with Raney Ni, gave deoxyteretifolione B (17). Coupling of 17 and 
2 equivalents of natural teretifolione B (4) in pyridine gave conocurvone (6), presumably via 1,4-addition 
of 4 to 17, simultaneous oxidation of resultant hydroquinone to quinone in aerobic condition, second 
addion of 4 to the quinone followed by re-oxidation. The semisynthetic 6 was identical with naturally 
occurring conocurvone (6) in the terms of spectroscopic data and anti-HIV activity profiles (EC50 0.02 
PM) (Scheme 1b). The anti-HIV activity of conocurvone (6) was demonstrated by its inhibition of both 
HIV-1 activity towards killing of human CEM-SS target cells and HIV-1 replication. The reaction of 5 
and naphthoquinone 18 in AcOH gave semisynthetic dimer 19 and trimer 20 (Scheme 1c).  The trimer 
20 showed similar anti-HIV activity to 6, however, semisynthetic dimer 18 showed no anti-HIV activity.  
Armstrong and coworkers4 examined the constituents of Conospermum brachyphyllium and reported the 
isolation of brachyphyllone (21), conocurvone (6), and teretifolione B (5) and its methylated derivative 
 (9). They also reported the direct semisynthesis of conocurvone (6) from teretifolione B (5), in which a 
mixture of teretifolione B (5) and p-TsCl in pyridine was heated under a dry air atmosphere to give 
conocurvone (6) in 10% yield (Scheme 2).  
 
 
Figure 2. Representative naphthoquinones isolated from Conospermum sp. by Cannon et al. 
 
 
Scheme 1. Derivatization of conocurvone (6) and teretifolione B (5) 
 
 
Scheme 2. Direct semisynthesis of conocurvone (6) from teretifolione B (5) 
 3. SYNTHESIS OF OLIGOMERIC NAPHTHOQUINONES AND THEIR BIOLOGICAL 
ACTIVITIES 
3-1. Formation of cyclic and acyclic trimeric naphthoquinones 
Pummerer et al.7 reported the oligomerization of monomeric naphthoquinones under both acidic (in 
AcOH) and basic (in pyridine) conditions. Brockmann8 explained that this oligomerization starts with the 
Michael reaction of 18 and a small amount of contaminated hydroquinone 22 to afford hydroquinone 
dimer 23. Bishydroquinone 23 reacts with quinone 18 and is converted to hydroquinone-quinone adduct 
24 and hydroquinone 22 via an auto-redox process. Further conjugate addition of 22 to 24 affords acyclic 
trimer 25, which cyclizes simultaneously under air to give cyclic trimer 27 via the assumed acyclic 
trimeric intermediate 26.8 This method was applied to the synthesis of natural cyclic trimer xylospyrin 
(28) via the trimerization of 7-methyljuglone (29) under similar reaction conditions (Scheme 3a). 
 
 
Scheme 3. Formation of cyclic 27 and 28, and acyclic 32 quinone trimers,  
by the cyclotrimerization of naphthoquinones 
 
Laatsch9 reported the formation of cyclic trimer 27 in the reaction of quinone-methylated hydroquinone 
adduct 30 and hydroquinone 22 in the presence of pyridine. The filtrate obtained after the removal of 
precipitated 27 was treated with Ag2O to afford a small amount of acyclic trimer 31 that could be 
converted to acyclic quinone trimer 32 via CAN oxidation (Scheme 3b).9 Thus, trimerization of the 
 simple naphthoquinones 22 gave mainly cyclic trimers. Prevention of the assumed cyclotrimerization of 
teretifolione B (5) to afford conocurvone (6) (vide infra) has been attributed to the hydroxy groups at 
position 8 in 5.10  
3-2. Synthesis of acyclic trimeric naphthoquinones using halogenated monomers 
Stagliano et al. examined the application of quinone iodonium salt 33 as a quinone 1,4-dipole for the 
synthesis of acyclic trimeric naphthalenes.11 A series of iodonium salts can be prepared by the reaction of 
2-hydroxynaphthoquinones and PhI(OAc)2.12 Stille coupling of the iodonium salt 33 and 
stannylbenzopyrane 34 in the presence of palladium catalysts gave dimer 35. After conversion of the 
hydroxy group in 35 to triflate 36, Stille coupling of 36 and stannane 37 gave 
2,3-bis(pyranonaphthyl)-1,4-naphthoquinone 38 (Scheme 4). 
 
 
Scheme 4. Synthesis of 2,3-bisnaphthylnaphthoquinone 38 by double Stille coupling 
 
Stagliano et al. 13 also reported the synthesis of oligomeric hydroxynaphthoquinones by a Michael 
addition-elimination sequence using 2,3-dichloronaphthoquinone 39 and 2-hydroxynaphthoquinone 40. 
The reaction of 39 and 1 mol equivalent of 40 in the presence of Cs2CO3 as a base gave dimer 41 after 
methylation of the hydroxy group using Meerwein reagent. The dimeric quinone 41 was further treated 
with hydroquinone potassium salts 42 in the presence of 18-crown-6 to give the trimeric naphthoquinones 
43. Condensation of 39 and 1 mol equivalent of teretifolione B (5) was examined under similar conditions 
to afford methylated unsymmetrical dimeric quinone 44. Several trimeric quinones prepared by this 
method were assayed for anti-HIV activity. Compound 45 showed weaker activity than did conocurvone 
(6) (Scheme 5).14 
  
Scheme 5. Synthesis of the partially methylated oligomeric naphthoquinones 43-45 
 
The synthesis of trimeric quinones by a similar method and their biological activities were examined by 
Crosby et al.15 The reaction of 2,3-dibromonaphthoquinone (46) and hydroxyquinone 47 in the presence 
of tertiary amine gave dimeric quinone 48, which was further treated with 47 under the same conditions 
to give trimeric quinone 49. A similar stepwise procedure provided asymmetric 50 and symmetric 
trimeric naphthoquinones 20 (Scheme 6). Screening the cytophathic effects of trimers 49, 50, and 20 
towards HIV-infected cells showed inhibitory activities comparable with conocurvone (6) but with lower 
selective indices.  
 
Scheme 6. Synthesis of trimeric naphthoquinones 49, 50, and 20 
 
 An approach for the synthesis of dimeric nitronaphthoquinones was examined by Stagliano et al. using 
2-hydroxy-3-nitronaphthoquinones.16 Mild conditions for the nitration of 2-hydroxynaphthoquinone 40 to 
nitroquinone 51 using nitronium tetrafluoroborate (NO2BF4) as a nitration reagent prevented 
decomposition of the benzopyrane moiety (i.e., 47) that occurs under highly acidic conditions. This 
reaction step gave a better yield than did the conventional method (e.g., aq. HNO3, CHCl3). After the 
conversion of 51 to cholide 52 using (COCl)2, regiospecific substitution of 52 with hydroxyquinone 53 in 
the presence of Cs2CO3 gave dimeric nitrobisnaphthoquinone 54. The methylation of 54 was followed by 
further substitution of the nitro group in 55 to chlorine to afford chloromethoxybiquinone 56. This 
method was applied to the synthesis of 3-hydroxy-3’-nitrobispyranonaphthoquinones 59 and 60, which 
can be converted to trimers using the reported procedure (Scheme 7).16 
 
 
Scheme 7. Synthesis of the dimeric naphthoquinones 56, 57 and 59  
via the nitronaphthoquinones 52 and 57 
 
3-3. Synthesis of acyclic trimeric naphthoquinones from phthaloyl-metal complexes 
Liebeskind et al.17 reported the synthesis of acyclic trimeric naphthoquinones by an insertion reaction of 
phthaloyl-metal complexes and bisnaphthylalkynes. The phthaloyl-metal complexes 60 were prepared by 
the reaction of phthaloxyl chlorides 61 or benzocyclobutane-1,2-diones 62 and various metal reagents. 
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 Formation of naphthoquinones 63 was observed when the phthaloyl-Fe and Co complexes of 60 were 
used in the insertion reaction with disubstituted alkynes 64. The addition of AgBF4 was necessary for 
reaction of the Co complex.17 This methodology was applied to the synthesis of trisnaphthoquinones. 
Examination of insertion reactions of the phthaloyl-metal complexes to bisnaphthoalkynes showed that 
the reaction of phthaloyl-Co complex with Cp ligand 65 and alkyne 66 under photoirradiation condition 
gives the desired trisquinone 67 as a Co complex. Treating the quinone-Co complex 67 with CAN gave 
the demetallated trisquinone 68 in high yield (Scheme 8).18  
 
 
Scheme 8. Synthesis of monomeric 63 and trimeric naphthoquinones 68  
via the insersion reaction of phthaloyl-metal complexes 60 and 65 to alkynes 64 and 66. 
 
4. PREVIOUS EXAMPLES OF SYNTHETIC STUDIES OF TERETIFOLIONES 
Several groups previously reported the total synthesis of teretiolfione B (5) and related compounds. In the 
total synthesis of racemic teretifolione B [(±)-5] by Cannon et al.,5 chromene substrate (±)-69 was 
obtained by the condensation reaction of naphthalene-2,7-diol (70) and enal 71 in the presence of pyridine. 
Chromene (±)-69 was converted to azo compound 72, and dithionite reduction followed by oxidation with 
FeCl3 yielded o-quinone 21. After further dithionite reduction of 21, the hydroquinone was subjected to 
autooxidation conditions under an oxygen atmosphere in the presence of t-BuOK to give the desired 
racemic teretifolione B [(±)-5] (Scheme 9a). The asymmetric synthesis of teretifolione B (5) was achieved 
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 by Vander Velde and Jacobsen19 through the kinetic resolution of racemic acetoxychromene 73 by 
epoxidation using the optically active salen-Mn complex 74, and mCPBA and NMO as co-oxidant and 
additive, respectively. The (S)-isomer of 73 was preferentially consumed to afford (R)-73 in 15% yield 
and 91% ee. Deprotection of the acetyl group in (R)-73 followed by a modified oxidation sequence for 
phenol (R)-69 and quinone (R)-21 yielded teretifolione B (5) with the same absolute configuration as the 
natural product (Scheme 9b).19 Stagliano and Malinakova20 reported the total synthesis of racemic 
methylteretifolione B [(±)-9]. Hydroxychromene 70 was protected by a MOM group, and the MOM ether 
75 was subjected to MOM-directed regioselective ortho lithiation and methylation to give 76. 
Deprotection and oxygenation of 76 afforded methylteretiforione B [(±)-9] (Scheme 9c).20  
 
 
Scheme 9. Reported total synthesis of teretifolione B (5) and methylteretifolione B [(±)-9]  
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 5. SYNTHESIS OF PYRANONAPHTHOQUINONES VIA THE DIELS-ALDER APPROACH 
5-1. Retrosynthesis 
Our synthetic study towards conocurvone (6) is based on the construction of the trimeric angular 
pyranonaphthoquinone framework by Diels-Alder reaction (DAR) of optically active pyranobenzyne 77 
and trimeric oxygenated furan 78. Natural monomeric teretifolione B 5 and methylated 9 would be 
accessed via DAR of 77 and monomeric furans 79 and 80. Benzyne 77 would be generated from iodo- 
triflate 81, which would be converted from optically active hydroxychromene 69. 69 would be 
synthesized by condensation of resorcinol (82) and citral (71) followed by optical resolution of (±)-69. 
Siloxyfurans 79 and 80 would be coverted from tetronic acids 83 and 84. In our first trial, we focused on 
DAR using methylated furan 79 for the synthesis of 9 because no asymmetric total synthesis of 9 has 
been reported to date (Scheme 10).  
 
 
Scheme 10. Retrosynthesis of conocurvone (6) and teretifoliones 5 and 9 via DAR of benzyne 77 and 
furans 79 and 80. Si = silyl protecting group.  
  
5-2. Naphthoquinone synthesis by Diels-Alder reaction of benzynes and substituted furans 
We examined the O-benzylation of methyltetronic acid (84) as a first step in the preparation of 
oxygen-substituted furans. Alkylation under basic conditions using a relatively less reactive alkyl halide 
such as EtI gave the corresponding O-alkylated product selectively, whereas use of the more reactive 
benzyl bromide gave a mixture of C- and O-alkylated products.21 Benzylation of 84 using benzyl bromide 
in the presence of K2CO3 gave the desired O-benzylated 85 in low yield (Table 1, run 1). In contrast, the 
use of CsF as a base provided C-benzylated furanone 86 as a major product (run 2). Application of 
BnOTs22 improved the ratio of O-/C-benzylation to 3:1 (run 3), and the desired 85 was afforded as the 
sole product when K2CO3 was used as a base (run 4). The corresponding O-benzylated products were 
 obtained in the reaction of other E-carbonyl compounds such as tetronic acid (84) and 
cyclopentane-1,3-dione using this method.  
Siloxyfuran 80 was prepared by the treatment of furanone 85 with TIPSOTf23 and subjected to DAR with 
benzyne in situ prepared by the reaction of iodophenyl triflate 87 and n-BuLi. The desired natural 
hydroxynaphthoquinone 88 and the benzyl ether 89 were obtained via formation of epoxynaphthalene 90 
and the FeCl3 oxidation of naphthol 94 (Scheme 11).24  
 
Table 1. Trials for O-selective benzylation of 84 
 
 
 
 
Scheme 11. Synthesis of naphthoquinones 88 and 89  
via DAR of iodophenyl triflate 87 and furan 88 
 
Scheme 12 illustrates the DAR approach to constructing the angular pyranonaphthoquinone core using 
pyranobenzyne. Iodination and introduction of a propargyl group to resorcinol benzoate (90) furnished 
propargyl ether 91, which was subjected to thermal Claisen rearrangement to give a mixture of the desired 
5-benzyloxy 92 and 7-benzyloxychromones 93 in the ratio 2:1. The benzoate 92 was converted to the 
corresponding triflate 94 as a benzyne precursor. DAR of the pyranobenzyne 95, derived from 94, and 
furan 80 gave a 1:2 isomeric mixture of the desired hydroxypyranonaphthoquinone 96 and the undesired 
regioisomer 97 via epoxynaphthalenes 98 and 99, respectively. Oxidation of hydroquinone 96 followed 
by deprotection of the benzyl group using BCl3 gave natural pyranonaphthoquinone 7. Trials for the 
oxidation of regioisomer 97 in the same manner gave complex mixtures, perhaps because the higher 
reactivity of 97 due to its 2,6-dihydroxynaphthalene moiety can result in oxidation to 
2,6-naphthoquinone-type compounds. The application of (diacetoxyiodo)benzene (PIDA)-oxidation in 
 methanol gave quinone monoacetal 100. Subsequent debenzylation and deacetalization using BCl3 gave 
101, the corresponding regioisomer of 7 (Scheme 12).25 
 
 
Scheme 12. Synthesis of pyranonaphthoquinones 7 and 101 
 
5-3. Total synthesis of teretifoliones 
The strategy described above was applied to the total synthesis of teretifolione B (5). Racemic chromene 
(±)-69 was prepared by the condensation reaction of resorcinol (82) and citral (71) using ethylenediamine 
as a catalyst, then was converted to the corresponding triflate (±)-81 as a benzyne precursor. Treatment of 
(±)-81 with n-BuLi in the presence of siloxyfuran 79 gave a regioisomeric mixture of epoxynaphthalenes 
102 and 103, which spontaneously isomerized to hydroquinones 104 and 105, respectively. After 
separation, 104 and 105 were subjected to FeCl3 oxidation to give benzyl-protected naphthoquinones 106 
and 107, which were hydrolyzed in basic conditions to give racemic teretifolione B [(±)-5] and its 
regioisomer 108. During the purification of 106, cyclized product 109 formed, presumably by the 
photo-irradiated [2+2] cycloaddition of 106. The application of ODS column chromatography under dark 
conditions suppressed this side reaction (Scheme 13).  
 
  
Scheme 13. Synthesis of racemic teretiofolione B [(±)-5] and its regioisomer 108 
 
Based on a report by Zammattio et al.,26 optically active chromene 69 was prepared by lipase-catalyzed 
kinetic resolution of racemic acetate (±)-109 under hydrolytic conditions. When (±)-109 was treated with 
Amano Lipase PS in H2O-saturated iPr2O, the hydrolyzed phenol 69 was obtained in 35% yield and 18% 
ee. We also examined transesterification conditions27 by conducting reactions using various enzymes and 
alcohols.  The reaction of 109 using tert-butyl alcohol and Amano Lipase PS in toluene gave optically 
active acetate 109 in 97% ee. Reaction in TBME and acetonitrile proceeded faster than in toluene and 
with similar enantioselectivity, whereas the application of hexanoyl or chloroacetyl ester decreased 
selectivity. The racemization of 69 (23% ee) under thermal conditions results in the recovery of (±)-69. 
The optically active acetate 109 was hydrolyzed to (R)-69, which was subjected to the same synthetic 
pathway described above to furnish teretifolione B (5) and its methyl derivative 9. Comparison of the 
optical rotations of natural and synthetic 5 and 9 revealed that both teretifolione B (5) and its methyl 
derivative 9 possess the (R) absolute configuration (Scheme 14).28,29  
 
 
Scheme 14. Enzymatic resolution of (±)-109 and the asymmetric total synthesis of teretifoliones 5 and 9  
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 6. CONCLUSION 
This review provided an overview of the chemistry of anti-HIV active trimeric pyranonaphthoquinone 
conocurvone and its monomeric teretifolione. Conocurvone was isolated from Conospermum plants as an 
anti-HIV-1 active compound. The structural determination of conocurvone was challenging due to the 
complexity of its spectral data arising from an assumed dynamic intramolecular process. Its structure was 
finally assigned as a trimeric pyranonaphthoquinone based on the derivatization of conocurvone and its 
semisynthesis from monomeric teretifolione B.  
Independent studies examined the trimerization of naphtho(hydro)quinones. The reaction of simple 
naphthoquinone furnished a cyclic trimer via conjugate addition of hydroquinone, a redox process, and 
oxidative cyclization. This approach succeeded in the synthesis of acyclic naphthoquinones using 
halogenated naphthoquinones to provide the conocurvone derivative, and several anti-HIV-active 
compounds with a trimeric quinone framework were identified. The methodology for the synthesis of 
trimeric naphthoquinones via the cycloaddition of phthaloyl-metal complexes and bisnaphthylalkynes is 
also noteworthy. 
Based on the background described above, we developed the total synthesis of monomeric teretifoliones 
by DAR of pyranobenzynes and oxygenated furans as a key step. Optically active pyranobenzyne 
precursor was prepared via enzymatic resolution of the racemic chromenes. The desired 
pyranonaphthoquinone framework was constructed by DAR of the corresponding furan and 
pyranobenzyne, and the total synthesis of teretifolione B and its methyl derivative was achieved. In future 
we anticipate reporting the total synthesis of conocurvone through the effective construction of optically 
active chromenes, improvement in the regioselectivity of DAR, and the synthesis of trimeric furans using 
DAR approaches. 
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